Stockholm Science City

Close menu

News

Ung Cancer (Young Cancer) aims to double its impact

The move to Hagastaden made Atlas Antibodies even stronger

New member of the board: Carl Johan Sundberg

Interdisciplinary collaboration maps the cellular and molecular landscape of childhood diseases

New team member at Stockholm Science City

Solution for analyzing DNA-associated diseases in sight

Meet the new Director of Research and Innovation

"Our work helps clients reduce risks in projects and avoid dead ends"

Alder Therapeutics is developing new cell therapy to prevent blindness

New opportunity for labs, offices, and networking in Hagastaden